Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30023045HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023046HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023047HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023048HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023049HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS44018658HTLV-1ENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TCGA Plot Options
Drug Information
GeneLCK
DrugBank IDDB16656
Drug NameZotiraciclib
Target IDBE0000842
UniProt IDP06239
Regulation Typeinhibitor
PubMed IDs33714981
CitationsChen R, Tsai J, Thompson PA, Chen Y, Xiong P, Liu C, Burrows F, Sivina M, Burger JA, Keating MJ, Wierda WG, Plunkett W: The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action. Blood Cancer J. 2021 Mar 13;11(3):57. doi: 10.1038/s41408-021-00436-0.
GroupsInvestigational
Direct Classification
SMILESCN1CC=CCCOC2=CC(=CC=C2)C2=CC=NC(NC3=CC=CC(C1)=C3)=N2
Pathways
PharmGKB
ChEMBLCHEMBL1944698